Skip to main content
PCRX
NASDAQ Life Sciences

EXPAREL 实际世界数据显示出显著的阿片类药物减少和 Medicare 髋关节患者的较低医疗费用

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
8
Price
$24.69
Mkt Cap
$992.407M
52W Low
$18.8
52W High
$27.64
Market data snapshot near publication time

summarizeSummary

Pacira BioSciences 公布了其旗舰产品 EXPAREL 的有力实际世界数据，证明了在 Medicare 患者接受全髋关节置换手术时，阿片类药物使用和总医疗费用显著减少。该研究在 ASRA 上发表，显示 EXPAREL 与标准护理相比，在 12 个月的期间内与明显降低的阿片类药物消耗、医疗资源利用和整体医疗费用相关联。这些积极的数据加强了 EXPAREL 的价值主张，为脆弱患者人群中增加采用提供了关键证据，并可能影响报销决策。这一发展是公司的一个积极催化剂，区别于最近的公司治理问题，并可能推动未来的销售增长

在该公告发布时，PCRX的交易价格为$24.69，交易所为NASDAQ，所属行业为Life Sciences，市值约为$9.9亿。 52周交易区间为$18.80至$27.64。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed PCRX - Latest Insights

PCRX
Apr 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
EXPAREL Real-World Data Reveals Significant Opioid Reduction, Lower Medical Costs for Medicare Hip Patients
Sentiment: Positive
View Wiseek Article
PCRX
Apr 17, 2026, 4:15 PM EDT
Filing Type: PREC14A
Importance Score:
8
Pacira BioSciences Faces Contested Director Election and Seeks Approval for Significant Equity Plan Expansion Amidst Activist Pressure
Sentiment: Negative
View Wiseek Article
PCRX
Apr 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
New Data Shows Pacira's EXPAREL Lowers Healthcare Costs, Opioid Use in Outpatient Orthopedic Surgeries
Sentiment: Positive
View Wiseek Article
PCRX
Mar 12, 2026, 7:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Activist DOMA Perpetual Nominates Directors, Demands CEO Replacement and Company Sale
Sentiment: Negative
View Wiseek Article
PCRX
Mar 11, 2026, 5:02 PM EDT
Source: GlobeNewswire
Importance Score:
8
Pacira Counters Activist Investor, Highlights Strategic Progress and Shareholder Returns
Sentiment: Neutral
View Wiseek Article
PCRX
Mar 11, 2026, 3:25 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Activist DOMA Perpetual Nominates Directors, Demands CEO Replacement & Formal Sale Process for Pacira BioSciences
Sentiment: Negative
View Wiseek Article
PCRX
Mar 11, 2026, 1:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Activist Investor Demands Pacira CEO Replacement, Cites IP Battle Risks
Sentiment: Negative
View Wiseek Article
PCRX
Feb 26, 2026, 4:16 PM EST
Filing Type: 10-K
Importance Score:
9
Pacira BioSciences Returns to Profitability in 2025 with Strong Revenue Growth and Strategic Progress
Sentiment: Positive
View Wiseek Article
PCRX
Feb 26, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
9
Pacira BioSciences Reports Strong 2025 Turnaround, Significant Share Repurchases, and Positive 2026 Outlook
Sentiment: Positive
View Wiseek Article
PCRX
Jan 28, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
8
Pacira BioSciences Appoints Dr. Samit Hirawat to Board Amidst Activist Investor Pressure
Sentiment: Positive
View Wiseek Article